BridgeMD
New treatment option for Fibromyalgia, Primary
Official title Preference of Women With Fibromyalgia Undergoing a Three Different Volumes of Resistance Training
ClinicalTrials.gov ID: NCT06424743
What this study is testing
- What it's testing
- Fibromyalgia is a painful syndrome of unknown etiology, which affects 2% of world population, with symptoms such as: pain, unrefreshing sleep, fatigue and mood disorders. It is already established in the literature that resistance training is part of the non- pharmacological treatment for patients with fibromyalgia.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 65, women only
You may be able to join if
- Women aged 18 to 65
- Have a diagnosis of fibromyalgia according to the ACR 2016 criteria
You likely can't join if
- Have performed resistance training in the last 6 months
- Having another associated rheumatic condition
- Have a trip or appointment scheduled that requires absence for the next 4 (four) weeks from the start of the survey;
- Women with musculoskeletal injuries in the upper and/or lower limbs
- Have heart problems that prevent maximal efforts and submaximums
The study team makes the final eligibility decision.
Where it's taking place
- Natal, Rio Grande do Norte, Brazil
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Natal, Rio Grande do Norte, Brazil. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.